AstraZeneca PLC (OTCMKTS:AZNCF) Sees Large Increase in Short Interest

AstraZeneca PLC (OTCMKTS:AZNCF) was the target of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 446,500 shares, an increase of 38.4% from the February 13th total of 322,700 shares. Based on an average daily volume of 4,500 shares, the short-interest ratio is currently 99.2 days.

AstraZeneca Stock Down 0.6 %

AstraZeneca stock opened at $153.56 on Friday. The company has a fifty day simple moving average of $143.21 and a 200-day simple moving average of $144.37. AstraZeneca has a 12-month low of $120.64 and a 12-month high of $175.00.

AstraZeneca Increases Dividend

The company also recently disclosed a dividend, which will be paid on Monday, March 24th. Stockholders of record on Friday, February 21st will be given a dividend of $2.10 per share. This is a boost from AstraZeneca’s previous dividend of $1.00. The ex-dividend date of this dividend is Wednesday, February 19th. AstraZeneca’s payout ratio is 343.14%.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.